** Shares in Carmat ALCAR.PA fall more than 10% after the
French artificial heart maker completed a capital increase of
10.3 mln euros ($11.5 mln)
** The group says this extends its cash position until the
beginning of 2025
** "This is only a short-term relief as the company still
needs c. EUR 36m to bridge the gap over the next 12-months,"
Degroof Petercam says, though it calls the news reassuring
** The broker cuts its PT by 27% to 6.2 euros
** The shares touch their lowest price ever at 1.40 euro per
share
** Carmat lowered its 2024 sales forecast to 8-12 million
euros in early September, citing reduced surgical activity in
Europe this summer
($1 = 0.8957 euros)
(Reporting by Olivier Cherfan)
((olivier.cherfan@thomsonreuters.com))